BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins. The Pharmaceuticals segment provides aid to patients over-exposed to certain cancer or vascular medications, or to toxins. The Licensing segment relates to the royalty payments for the use of the company's intellectual property. The company was founded in 1981 and is headquartered in London, the United Kingdom.